UNICELL-2019-nCoV Neutralization Antibody Test

UNICELL-2019-nCoV NAb (Neutralization Antibody) assay is a Fluorescent Immunoassays (FIA) for the quantitative determination of 2019-nCoV Neutralization Antibodies in human serum or plasma.
Category
COVID-19
Product Overview

UNICELL-2019-nCoV NAb (Neutralization Antibody) assay is a Fluorescent Immunoassays (FIA) for the quantitative determination of 2019-nCoV Neutralization Antibodies in human serum or plasma. This assay can simulate the in vivo binding of SARS-CoV-2 RBD to ACE2-receptor in human host cells after SARS-CoV-2 infection or vaccination.

 

UNICELL-2019-nCoV NAb (Neutralization Antibody) assay is a Fluorescent Immunoassays (FIA) for the quantitative determination of 2019-nCoV Neutralization Antibodies in human serum or plasma. This assay can simulate the in vivo binding of SARS-CoV-2 RBD to ACE2-receptor in human host cells after SARS-CoV-2 infection or vaccination.

 

Features:

●Convenient: Easy operation with minimal maintainence required

●Automation: Perform Neutralization Antibody test on a standardized POCT platform

●Testing Flexibility: Flexible testing capacity, first result within 15 minutes,3 different test modes

 

 

 

Hot Tags: unicell-2019-ncov neutralization antibody test,sars-cov-2 test,vaccination,covid19vaccination, Novel Coronavirus Immunoassaypoint of care testing productschemiluminescence immunoassay (clia) analyzerscovid19 testing2019-nCoV Neutralization Antibody TestUNICELL-2019-nCoV Rapid Antigen Test

Language
Search
亚辉龙

Join Us

关注我们

Wechat

Headquarter: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China

Follow YHLO

wechatwechat wechat wechat wechat

© 2020  Shenzhen YHLO Biotech Co., Ltd.  All rights reserved.  粤ICP备19040167号